Categories: Business

Embolx Launches Sniper G3: Revolutionizing Embolization with Enhanced Efficiency, Ease of Use, and Extended Shelf Life

SUNNYVALE, Calif., July 28, 2025 /PRNewswire/ — Embolx, a leader in advanced microcatheters for targeted embolization procedures, today announced the release of its next-generation Sniper G3 Balloon Occlusion Microcatheter. This third iteration of the innovative device delivers significant enhancements, including an extended shelf life, improved ease of use, and streamlined preparation, directly addressing critical feedback from physician users.

- Advertisement -

The highly anticipated Sniper G3 features a 24-month shelf life, doubling the longevity of its predecessor. This improvement offers greater inventory flexibility for hospitals and clinics. Designed with direct input from interventional radiologists, Sniper G3 also features improved trackability and a simplified preparation process, significantly reducing pre-procedure setup time. The new prep method eliminates several steps, cutting preparation time down to less than a minute, a crucial gain in fast-paced clinical environments. This focus on user feedback underscores Embolx’s commitment to developing intuitive, high-performance tools that enhance clinical workflow.

- Advertisement -

Sniper G3 truly exemplifies our dedication to innovation driven by physician needs,” said Michael Allen, President and CEO of Embolx. “We listened intently to our users and engineered a device that not only extends product longevity and improves performance, but also significantly enhances the ease of use, which translates directly to more efficient procedures. We are incredibly proud of Sniper G3 and its potential to set a new standard in embolization therapy.”

- Advertisement -

The Sniper G3 Balloon Occlusion Microcatheter represents a significant leap forward in Embolx’s commitment to physician-centric innovation. It is available in all standard lengths and is ready for worldwide distribution.

- Advertisement -

About Embolx
Embolx has pioneered advanced pressure-mediated delivery of therapeutics directly into cancerous tumors, prostates, and other anatomical structures and is dedicated to transforming healthcare through the development of innovative technologies.

- Advertisement -

For media inquiries, please contact:

- Advertisement -

Haley McGregor
Global Marketing and Sales Operations Manager
hmcgregor@embolx.com

- Advertisement -

Logo – https://mma.prnewswire.com/media/2738641/Sniper_g3_Logo.jpg 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/embolx-launches-sniper-g3-revolutionizing-embolization-with-enhanced-efficiency-ease-of-use-and-extended-shelf-life-302514310.html

- Advertisement -
PRNW Agency

Recent Posts

MUFG Bank, Ltd. announces Consolidated Summary Report [under Japanese GAAP] for the six months ended September 30, 2025

TOKYO--(BUSINESS WIRE)--MUFG Bank, Ltd.: Company name: Mitsubishi UFJ Financial Group, Inc. Stock exchange listings: Tokyo,…

2 hours ago

Mitsubishi Electric Hydronics & IT Cooling Systems and BITZER Khlmaschinenbau to Establish Joint Venture for HVAC Compressor Development

Will support globally optimized solutions for applied HVAC and IT cooling systemsTOKYO--(BUSINESS WIRE)--Mitsubishi Electric Corporation…

2 hours ago

Daimler India Commercial Vehicles under new leadership

Torsten Schmidt will become the new Managing Director & CEO of Daimler India Commercial Vehicles…

2 hours ago

GSMA MWC26 Barcelona countdown begins with thought leaders cleared for take-off from SpaceX and Starlink

Registration opens with new dynamic and immersive show floor experiences revealed, including 4YFN, Airport of…

2 hours ago

PR Newswire Powers the AI Era, Embracing the Future of AI Search and Information Discovery

HONG KONG, Nov. 14, 2025 /PRNewswire/ -- PR Newswire is committed to an open-access policy…

4 hours ago